ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Elucidating the Genetic Background of End Stage Renal Disease of Unknown Aetiology in Patients Listed for Kidney Transplantation

E. Leenen1, B. Beck2, A. Joerres1, A. Weidemann1

1Department of Medicine I - Nephrology, Transplantation & Medical Intensive Care, Medical Center Cologne-Merheim, Cologne, Germany, 2Institute of Human Genetics University Hospital Cologne, Medical Center Cologne-Merheim, Cologne, Germany

Meeting: 2020 American Transplant Congress

Abstract number: D-012

Keywords: Fibrosis, Genomics, Glomerular filtration rate (GFR), Kidney transplantation

Session Information

Session Name: Poster Session D: Kidney Living Donor: Other

Session Type: Poster Session

Date: Saturday, May 30, 2020

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

*Purpose: The prevalence of end stage renal disease (ESRD) of unknown aetiology in adult patients accounts for almost 20% of all dialysis patients in Europe. Genetic causes for renal disease are well established in paediatric nephrology. Recent studies suggest that the proportion of adult patients with a causal genetic variant has been underestimated dramatically. Next generation sequencing (NGS) substantially improved the identification of mutations leading to ESRD with a great impact on the management of such patients. An accurate genetic diagnosis helps identifying comorbidities at an early stage, stratifying the risk of recurrence as well as evaluating potential living kidney donor candidates. Therefore, this now cost- and time-efficient diagnostic approach should be aimed at whenever possible.

*Methods: Over 300 adult patients are listed for kidney transplantation at our center. Patients with ESRD of unknown aetiology at an age below 40, positive family history and/or typical extrarenal manifestations have been selected. These pre-selected patients were analyzed for causal genetic variants by NGS-based sequencing methods.

*Results: 25% of all patients awaiting kidney transplantation (n=316) were diagnosed with ESRD of unknown aetiology. Within this group we determined more than 10 families showing nephropathies with distinct patterns of inheritance. So far, we identified causal genetic variants in the following genes: Uromodulin (UMOD), MUCIN-1 (MUC-1), LIM Homeobox Transcription Factor 1 Beta (LMX1B), Hepatocyte Nuclear Factor (HNF1ß) and Alpha-5-Collagen-Typ-IV (COL4A5). For the latter we are the first to demonstrate a pedigree and a genotype-phenotype-association for this novel genetic variant.

*Conclusions: Hereditary nephropathies are very difficult to diagnose clinically and are therefore likely to be underestimated regarding frequency and significance. This highlights the importance of NGS-based genetic testing in patients with ESRD of unknown aetiology and a positive family history with regards to kidney transplantation. Selection of an appropriate NGS-approach and interpretation of the obtained data is challenging and requires a multidisciplinary work combining the expertise of geneticists and nephrologists. With this study we hope to raise awareness and promote the understanding of rare hereditary nephropathies with adult onset.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Leenen E, Beck B, Joerres A, Weidemann A. Elucidating the Genetic Background of End Stage Renal Disease of Unknown Aetiology in Patients Listed for Kidney Transplantation [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/elucidating-the-genetic-background-of-end-stage-renal-disease-of-unknown-aetiology-in-patients-listed-for-kidney-transplantation/. Accessed May 24, 2025.

« Back to 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences